Gene therapy strategies for leukemia

S. E. Braun, K. Chen, M. Battiwalla, Kenneth Cornetta

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

A number of diverse gene therapy strategies are being evaluated in the search for novel therapeutic approaches to leukemia. Antisense oligonucleotides, ribozymes and retroviral vectors are approaches directed at the molecular mechanisms of cancer. Transfer of genes encoding cytokines and human leukocyte antigens (HLAs) could also be used to elicit immunity against tumor cells. Gene marking strategies have been useful in elucidating the biology of disease relapse after autologous bone marrow transplantation. Suicide genes, such as the herpes simplex thymidine kinase gene, have been used to modulate graft-versus-host disease after allogeneic bone marrow transplantation. Although gene delivery remains a major challenge to gene therapy, some modifications have been implemented to overcome this issue. This review will summarize these gene therapy strategies aimed at increasing the survival of patients with leukemia.

Original languageEnglish
Pages (from-to)39-46
Number of pages8
JournalMolecular Medicine Today
Volume3
Issue number1
DOIs
StatePublished - 1997

Fingerprint

Genetic Therapy
Leukemia
Genes
Bone Marrow Transplantation
Catalytic RNA
Herpes Simplex
Thymidine Kinase
Autologous Transplantation
Antisense Oligonucleotides
Homologous Transplantation
Graft vs Host Disease
HLA Antigens
Suicide
Immunity
Neoplasms
Cytokines
Recurrence
Survival
Therapeutics

ASJC Scopus subject areas

  • Genetics
  • Molecular Medicine

Cite this

Gene therapy strategies for leukemia. / Braun, S. E.; Chen, K.; Battiwalla, M.; Cornetta, Kenneth.

In: Molecular Medicine Today, Vol. 3, No. 1, 1997, p. 39-46.

Research output: Contribution to journalArticle

Braun, S. E. ; Chen, K. ; Battiwalla, M. ; Cornetta, Kenneth. / Gene therapy strategies for leukemia. In: Molecular Medicine Today. 1997 ; Vol. 3, No. 1. pp. 39-46.
@article{47c6f224c0204248a91e8a72374953d4,
title = "Gene therapy strategies for leukemia",
abstract = "A number of diverse gene therapy strategies are being evaluated in the search for novel therapeutic approaches to leukemia. Antisense oligonucleotides, ribozymes and retroviral vectors are approaches directed at the molecular mechanisms of cancer. Transfer of genes encoding cytokines and human leukocyte antigens (HLAs) could also be used to elicit immunity against tumor cells. Gene marking strategies have been useful in elucidating the biology of disease relapse after autologous bone marrow transplantation. Suicide genes, such as the herpes simplex thymidine kinase gene, have been used to modulate graft-versus-host disease after allogeneic bone marrow transplantation. Although gene delivery remains a major challenge to gene therapy, some modifications have been implemented to overcome this issue. This review will summarize these gene therapy strategies aimed at increasing the survival of patients with leukemia.",
author = "Braun, {S. E.} and K. Chen and M. Battiwalla and Kenneth Cornetta",
year = "1997",
doi = "10.1016/S1357-4310(96)10052-6",
language = "English",
volume = "3",
pages = "39--46",
journal = "Trends in Molecular Medicine",
issn = "1471-4914",
publisher = "Elsevier Limited",
number = "1",

}

TY - JOUR

T1 - Gene therapy strategies for leukemia

AU - Braun, S. E.

AU - Chen, K.

AU - Battiwalla, M.

AU - Cornetta, Kenneth

PY - 1997

Y1 - 1997

N2 - A number of diverse gene therapy strategies are being evaluated in the search for novel therapeutic approaches to leukemia. Antisense oligonucleotides, ribozymes and retroviral vectors are approaches directed at the molecular mechanisms of cancer. Transfer of genes encoding cytokines and human leukocyte antigens (HLAs) could also be used to elicit immunity against tumor cells. Gene marking strategies have been useful in elucidating the biology of disease relapse after autologous bone marrow transplantation. Suicide genes, such as the herpes simplex thymidine kinase gene, have been used to modulate graft-versus-host disease after allogeneic bone marrow transplantation. Although gene delivery remains a major challenge to gene therapy, some modifications have been implemented to overcome this issue. This review will summarize these gene therapy strategies aimed at increasing the survival of patients with leukemia.

AB - A number of diverse gene therapy strategies are being evaluated in the search for novel therapeutic approaches to leukemia. Antisense oligonucleotides, ribozymes and retroviral vectors are approaches directed at the molecular mechanisms of cancer. Transfer of genes encoding cytokines and human leukocyte antigens (HLAs) could also be used to elicit immunity against tumor cells. Gene marking strategies have been useful in elucidating the biology of disease relapse after autologous bone marrow transplantation. Suicide genes, such as the herpes simplex thymidine kinase gene, have been used to modulate graft-versus-host disease after allogeneic bone marrow transplantation. Although gene delivery remains a major challenge to gene therapy, some modifications have been implemented to overcome this issue. This review will summarize these gene therapy strategies aimed at increasing the survival of patients with leukemia.

UR - http://www.scopus.com/inward/record.url?scp=0031408818&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031408818&partnerID=8YFLogxK

U2 - 10.1016/S1357-4310(96)10052-6

DO - 10.1016/S1357-4310(96)10052-6

M3 - Article

VL - 3

SP - 39

EP - 46

JO - Trends in Molecular Medicine

JF - Trends in Molecular Medicine

SN - 1471-4914

IS - 1

ER -